Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Controlled Trial Using CPV Vignettes to Assess the Clinical Utility of Natera Dd-cfDNA Test to Detect Allograft in Post-Transplant Patients

NCT03765203 is registered in ClinicalTrials.gov with Qure Healthcare, LLC as lead sponsor.

NCT NCT03765203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03765203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Controlled Trial Using CPV Vignettes to Assess the Clinical Utility of Natera Dd-cfDNA Test to Detect Allograft in Post-Transplant Patients
Lead sponsor
Qure Healthcare, LLC
Phase
Not applicable
Overall status
Completed
Start date
November 5, 2018
Completion date
January 7, 2019
Enrollment
175 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transplant;failure,kidney